BISTTRY10:00Live
Türk İlaç ve Serum Sanayi A.Ş. (TRILC) traded at TRY 0.91 as of 28/09/2026, a daily change of 1.11%. The company has a market capitalisation of TRY 943.7M, a P/E ratio of —, a P/B ratio of 0.48 and a free float of 73.16%. The stock belongs to the Chemicals, Petroleum, Rubber and Plastics sector, trades on the Watchlist Market and is a constituent of the indices. Our AI fair value model estimates TRY 0.81 (−11.33%). Technically the trend is classified as bearish and momentum as overbought.
According to our AI technical signal, the TRILC trend is bearish and momentum is overbought. Our AI fair value model estimates TRY 0.81, −11.33% from the current price. This data is for information only as of Sep 28, 2026; it is not investment advice.
Our AI fair value model estimates TRY 0.81 (−11.33%).
In the 28/09/2026 session TRILC traded at TRY 0.91, a daily change of 1.11%, with a day range of TRY 0.91 – 0.91 and a turnover of TRY 206.8K. Previous close: TRY 0.90. Data is delayed by 15 minutes.
TRILC (Türk İlaç ve Serum Sanayi A.Ş.) is at TRY 0.91 as of 28/09/2026, a daily change of 1.11%. Prices are delayed by 15 minutes; live prices require a Plus membership.
TRILC has a P/E ratio of —, a P/B ratio of 0.48, an EV/EBITDA of 3.68 and a market cap of TRY 943.7M. Ratios use the latest financial statements and the current price.
Türk İlaç ve Serum Sanayi A.Ş. belongs to the Chemicals, Petroleum, Rubber and Plastics sector and trades on the Watchlist Market. Index memberships: —.
The trailing dividend yield of TRILC is calculated at —%.
Our fair value model estimates TRY 0.81 for TRILC, a difference of −11.33% from the current price. The model was updated on July 21, 2026. This is not investment advice.
Stocks in the same sector with similar price behaviour to TRILC: MEGAP, KOTON, MNDTR, DYOBY, TSGYO, YESIL, ALGYO, EUREN.
Price, ratio and company data come from IdealData, a licensed Borsa Istanbul data vendor; analyst targets from broker research; AI indicators from Yatırımcı.AI models. Prices are delayed 15 minutes, ratios refresh daily and financial statements after each KAP disclosure.
AI-generated · may contain errors · not investment advice
| Item | 2026/3 (TRY) | YoY change |
|---|---|---|
| Revenue (TTM) | 5.1B | 12.07% |
| EBITDA (TTM) | 1.4B | 12.07% |
| Net income (TTM) | −83.8M | 87.76% |
| Equity | 2B | 9.74% |
| Total assets | 8.5B | 86.62% |